Yes, you did bring it up first. Probably another sign we

New Post Public Reply Private Reply Replies (1) Message Board
F1ash Drano #16619
Yes, you did bring it up first. Probably another sign we are being watched. A certain poster over there was just using it as bait to draw replies he could TOS as off topic. His M.O. is to throw out posts arguing semantics and get people mad enough to go off topic. What a child.
Funny how they neglected to mention why they chose the lowest dose of SGX942. I couldn't find the Phase 2 data to check. As far as swallowing a little Brilacidin, I believe it is not orally available so I suspect any issues from swallowing a tiny amount should be limited to the digestive tract. I read it is mint flavored by the way. Good choice IMHO.

So glad to hear about that KBIO Ceo being arrested. Someone mentioned Leo has met with a higher level FBI representative. I'll bet some people involved with Mako and Rosen are getting very nervous on the Shkreli arrest news. To my mind (if their is a silver lining to the Mako attack) its that if Cellceutix were guilty of lying as Mako suggested why in the hell would Cellceutix want the SEC and FBI involved?

Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

DC Renovation and Remodeling Earns Top Client Ratings Recognition

Updated Category News Views 195

DC Renovation and Remodeling Celebrated for Client Satisfaction DC Renovation and Remodeling has achieved noteworthy recognition from Find Local Contractors, being named a Top Client Rated Kitchen and Basement Renovation Contractor. This accolade is based on the company’s impressive five-star reviews from delighted customers, illustrating their dedication to exceptional...

Continue Reading
Neuronetics Achieves Remarkable Growth in Financial Performance

Updated Category News Views 135

Neuronetics' Impressive Financial Growth in Q2 2025 Neuronetics, Inc., a leader in neurohealth technology, announced its financial and operational achievements for the second quarter of 2025, showcasing remarkable results that signal a new era of success for the company. Quarterly Highlights and Financial Performance During the second quarter of 2025, Neuronetics reported...

Continue Reading
Understanding Market Sentiment Around Lemonade's Short Interest

Updated Category News Views 272

Insight Into Lemonade's Market Short Interest Lemonade's LMND short interest has increased recently, reflecting growing market observations. The latest reports indicate that there are approximately 17.65 million shorted shares, equating to about 31.95% of the total available shares for trading. With current trading volumes in mind, it would take traders roughly 7.63 days...

Continue Reading
SkinVision Pro: Transforming Dermatology Workflow Globally

Updated Category News Views 11

SkinVision Pro: Bridging Gaps in Dermatology There's a new sheriff in town for dermatology, and it's the SkinVision Pro. Launched at the HLTH Europe, this AI-powered platform is stepping up to modernize how skin health is managed globally. As skin cancer runs rampant with statistics that could send chills down anyone's spine, patient-doctor skin health communication...

Continue Reading
Lucid Group Reports Projected Loss Amid Investment Boost

Updated Category News Views 56

Lucid Group, the electric vehicle manufacturer, faced a harsh reality check back in 2024 when it announced an operational loss that came in way over estimates—between $765 million and $790 million for Q3. Just to put that into perspective, analysts were bracing for a loss of around $751.65 million, but Lucid threw them a curveball. The result? A 12% drop in its stock...

Continue Reading